Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
Saved in:
| Title: | Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial. |
|---|---|
| Authors: | Corbeau A; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: a.corbeau@erasmusmc.nl., Spampinato S; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Charnalia M; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Ranjan N; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., Gupta S; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., Kannan S; Epidemiology and Clinical Trials Unit, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Dora T; Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, A Unit of Tata Memorial Centre, Punjab, India., Engineer R; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., Maheshwari A; Department of Gynecologic Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., Mittal P; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., Jain J; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Gupta A; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Panda S; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Ghosh J; Department of Medical Oncology, Adva Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India., Sawant P; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India., de Boer S; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Hoogeman M; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Medical Physics & Informatics, HollandPTC, Delft, the Netherlands., Nout R; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Chopra S; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India. |
| Source: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 May; Vol. 218, pp. 111444. Date of Electronic Publication: 2026 Feb 14. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41698508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Corbeau+A%22">Corbeau A</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: a.corbeau@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Spampinato+S%22">Spampinato S</searchLink>; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Charnalia+M%22">Charnalia M</searchLink>; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Ranjan+N%22">Ranjan N</searchLink>; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Kannan+S%22">Kannan S</searchLink>; Epidemiology and Clinical Trials Unit, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Dora+T%22">Dora T</searchLink>; Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, A Unit of Tata Memorial Centre, Punjab, India.<br /><searchLink fieldCode="AU" term="%22Engineer+R%22">Engineer R</searchLink>; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Maheshwari+A%22">Maheshwari A</searchLink>; Department of Gynecologic Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Mittal+P%22">Mittal P</searchLink>; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Jain+J%22">Jain J</searchLink>; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Gupta+A%22">Gupta A</searchLink>; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Panda+S%22">Panda S</searchLink>; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Ghosh+J%22">Ghosh J</searchLink>; Department of Medical Oncology, Adva Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Sawant+P%22">Sawant P</searchLink>; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22de+Boer+S%22">de Boer S</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogeman+M%22">Hoogeman M</searchLink>; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Medical Physics & Informatics, HollandPTC, Delft, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nout+R%22">Nout R</searchLink>; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Chopra+S%22">Chopra S</searchLink>; Department of Radiation Oncology, Advanced Centre for Treatment and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228407192%22">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</searchLink> [Radiother Oncol] 2026 May; Vol. 218, pp. 111444. <i>Date of Electronic Publication: </i>2026 Feb 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8407192 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0887 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201678140%22">01678140 </searchLink><i>NLM ISO Abbreviation: </i>Radiother Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41698508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.radonc.2026.111444 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 111444 Titles: – TitleFull: Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Corbeau A – PersonEntity: Name: NameFull: Spampinato S – PersonEntity: Name: NameFull: Charnalia M – PersonEntity: Name: NameFull: Ranjan N – PersonEntity: Name: NameFull: Gupta S – PersonEntity: Name: NameFull: Kannan S – PersonEntity: Name: NameFull: Dora T – PersonEntity: Name: NameFull: Engineer R – PersonEntity: Name: NameFull: Maheshwari A – PersonEntity: Name: NameFull: Mittal P – PersonEntity: Name: NameFull: Jain J – PersonEntity: Name: NameFull: Gupta A – PersonEntity: Name: NameFull: Panda S – PersonEntity: Name: NameFull: Ghosh J – PersonEntity: Name: NameFull: Sawant P – PersonEntity: Name: NameFull: de Boer S – PersonEntity: Name: NameFull: Hoogeman M – PersonEntity: Name: NameFull: Nout R – PersonEntity: Name: NameFull: Chopra S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0887 Numbering: – Type: volume Value: 218 Titles: – TitleFull: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Type: main |
| ResultId | 1 |
